Romidepsin(CAS: 128517-07-7)

Romidepsin, also known as FP-3339A, is a potent and selective histone deacetylase inhibitor with the chemical formula C24H26N2O5. It is used in the treatment of cutaneous T-cell lymphoma and is under investigation for other diseases. Romidepsin is a white to off-white powder that is poorly soluble in water and soluble in organic solvents.

Romidepsin is primarily used in the treatment of cutaneous T-cell lymphoma. It is also being investigated for its potential applications in other hematologic malignancies and solid tumors. Romidepsin is a key compound in pharmaceutical research for epigenetic modulation and cancer therapy.

Romidepsin is generally safe when used under medical supervision. However, it can cause side effects such as nausea, fatigue, and peripheral neuropathy. Proper training and adherence to safety protocols are essential to ensure safety. Patients should avoid contact with the skin and eyes and use appropriate protective equipment during administration and handling.

Romidepsin should be stored in a tightly sealed container at room temperature (15-30°C) and protected from light. It should be kept away from moisture and heat. The container should be stored in a dry place and protected from direct sunlight. Proper labeling and storage conditions are critical to maintain the stability and efficacy of Romidepsin.